Syncom Formulations (India) Ltd Sustainability Reports
Syncom Formulations (India) Limited manufactures and markets a diverse range of pharmaceutical formulations across multiple dosage forms, including tablets, capsules, inhalers, and injections. The company distributes its products domestically in India and exports to over 15 countries worldwide.
Sector: Manufacturing
Country: India
Exchange: Bombay Stock Exchange
LEI: 335800QILNIFQEETDU74
FIGI: BBG001S861V6
13 reports from 2010 to 2025
- Syncom Formulations (India) Ltd 2025 Business Responsibility and Sustainability Report (BRSR)
- Syncom Formulations (India) Ltd 2025 Annual Report
- Syncom Formulations (India) Ltd 2024 Business Responsibility & Sustainability Report
- Syncom Formulations (India) Ltd 2024 Annual Report
- Syncom Formulations (India) Ltd 2023 Business Responsibility & Sustainability Report